This site is intended for US health care professionals only.

IMPORTANT SAFETY INFORMATION

This site is intended for US healthcare professionals only.

WARNING: ABUSE AND DEPENDENCE

  • CNS stimulants (amphetamines and methylphenidate-containing products), including Vyvanse, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.
Full Safety Information Below

Vyvanse is indicated for the treatment of moderate to severe binge eating disorder (B.E.D.) in adults. Vyvanse is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Vyvanse for the treatment of obesity have not been established.

Binge Eating Disorder in Adults Resource Center

Use these educational resources to learn about Binge Eating Disorder (B.E.D.) in adults and the diagnostic criteria.

Educational downloads

  • Adult Binge Eating Disorder Patient Screener

    Use this B.E.D. screener to help you begin the evaluation process with adult patients that may have Binge Eating Disorder.

    Download
  • Discussion Guide for Adult Patients with Binge Eating Disorder

    Use this guide to help you begin a dialogue about B.E.D. with adult patients.

    Download

Additional resources

  • B.E.D.Pro Resource™

    Stay up to date on the latest news and information about B.E.D. in adults.

    Register

Educational videos

  • How does the prevalence of B.E.D. in adults compare to that of other eating disorders?

    Learn how the prevalence of B.E.D. compares to the prevalence of other eating disorders in adults.

    Watch

  • To make a diagnosis of B.E.D. in adult patients, what are the essential features?

    Get information about the essential features for a diagnosis of B.E.D. in adult patients.

    Watch

  • How does the prevalence of B.E.D. in US adults compare among different races/ethnicities?

    See how the prevalence of B.E.D. compares among races and ethnicities in adults.

    Watch

  • How is B.E.D. in adults distinct from overeating and obesity?

    See the ways that B.E.D. in adults is distinct from overeating and obesity.

    Watch

  • How is B.E.D. distinct from bulimia nervosa in adults?

    See the ways that B.E.D. is distinct from bulimia nervosa in adults.

    Watch

  • What is the age of onset for B.E.D. in adults?

    Get information about the age of onset for B.E.D. in adults.

    Watch

  • Is there a relationship between obesity and B.E.D. in adults?

    Learn about the relationship between obesity and B.E.D. in adults.

    Watch

  • How can clinicians start the conversation with adults in their practice about Binge Eating Disorder?

    See how you can begin an effective conversation with your adult patients about B.E.D.

    Watch

You can either give your adult patients these educational materials, or you can use them when speaking with your adult patients to help facilitate an informed and meaningful conversation.

Educational downloads

  • Proper Use of Prescription Stimulants Brochure

    Help your adult patients understand the proper use of stimulant medications.

    Download

Shire Resources

  • Shire Cares

    Shire Cares is dedicated to assisting patients with limited financial resources.

    Find out more

Organizations

Shire

All content of this Web site including text, images, graphics, sound files, and their arrangements, belongs to Shire and is protected by international copyrights laws. All other intellectual property rights are reserved. The content may not be copied for commercial use or distribution nor may these objects be downloaded, modified, or posted to other sites.

This site is intended solely for US residents and is governed solely by US laws and government regulations. Please see our online privacy policy for more information. While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.

AdChoices

S38425  04/18

You are about to leave vyvansepro.com.

Please be advised that Shire has no control over the content or presentation of the site you are about to view.

Cancel Continue